New Key Statistics Module, Z-Score and F-Score
NAS:GLUE Key Ratios
| Market Cap $ M | 388.49 |
| Enterprise Value $ M | 170.64 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.53 |
| Price/Sales | 66.79 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 5.00 |
| EPS (TTM) $ | -2.24 |
| Beneish M-Score | 0 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.91 |
| EV-to-EBITDA | -0.96 |
| PEG | -- |
| Shares Outstanding M | 61.37 |
| Net Margin (%) | -2,264.53 |
| Operating Margin % | -2,420.89 |
| Pre-tax Margin (%) | -2,256.12 |
| Quick Ratio | 6.56 |
| Current Ratio | 6.56 |
| ROA % (ttm) | -45.12 |
| ROE % (ttm) | -68.31 |
| ROIC % (ttm) | -154.64 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.42 |
GLUE Number of Guru Trades
GLUE Volume of Guru Trades
Gurus Latest Trades with NAS:GLUE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:GLUE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Monte Rosa Therapeutics Inc Insider Transactions
No Available Data
News about NAS:GLUE
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers